SCRI HealthOne

Denver, Colorado 80218

2 studies enrolling now · 4 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, BRAF Gene Mutation, CRAF Gene Mutation, Castration-Resistant Prostate Cancer (CRPC), Melanoma, Metastatic Cancer, Metastatic Solid Tumor, NF1 Mutation, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, RAF Mutation

Studies at this site

• A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors — Recruiting now
• A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 — Recruiting now
• Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway — Stopped early
• A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors — Stopped early